Accessibility Menu
 

Mosaic ImmunoEngineering

(OTC) CPMV

Current Price$0.69
Market Cap$5.03M
Since IPO (2020)-86%
5 Year-77%
1 Year+7%
1 Month+1%

Mosaic ImmunoEngineering Financials at a Glance

Market Cap

$5.03M

Revenue (TTM)

$0.00

Net Income (TTM)

$687.85K

EPS (TTM)

$-0.10

P/E Ratio

-7.31

Dividend

$0.00

Beta (Volatility)

-0.55 (Low)

Price

$0.69

Volume

4

Open

$0.33

Previous Close

$0.69

Daily Range

$0.33 - $0.69

52-Week Range

$0.25 - $1.05

CPMV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mosaic ImmunoEngineering

Industry

Biotechnology

Employees

7

CEO

Steven W. King

Headquarters

Huntington Beach, CA 94947, US

CPMV Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

10%

Return on Assets

-35%

Earnings Yield

-13.68%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.03M

Shares Outstanding

7.24M

Volume

4

Short Interest

0.00%

Avg. Volume

394.661

Financials (TTM)

Gross Profit

$0.00

Operating Income

$616.12K

EBITDA

$616.12K

Operating Cash Flow

$111.40K

Capital Expenditure

$0.00

Free Cash Flow

$111.40K

Cash & ST Invst.

$3.62K

Total Debt

$1.47M

Mosaic ImmunoEngineering Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$5.03M

N/A

Market Cap/Employee

$2.52M

N/A

Employees

2

N/A

Net Income

$169.14K

-10.5%

EBITDA

$162.14K

-25.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$1.46M

+1.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.47M

+5.3%

Short Term Debt

$0.00

-100.0%

Return on Assets

-34.60%

N/A

Return on Invested Capital

10.25%

N/A

Free Cash Flow

$276.56K

-1235.0%

Operating Cash Flow

$276.56K

-1235.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BZYRBurzynski Research Institute, Inc.
$0.03+60.00%
PHRRFPharmaTher Holdings Ltd.
$0.07-6.70%
BIXTBioxytran, Inc.
$0.04-3.05%
GLWLFGlow Lifetech Corp.
$0.04+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$10.33+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.02-0.07%
TQQQProShares Trust - ProShares UltraPro Qqq
$59.22-0.02%
AALAmerican Airlines Group
$11.78+0.02%

Questions About CPMV

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.